COMMUNIQUÉS West-GlobeNewswire

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain
30/04/2025
Initial trial phase (“PoC 1”) achieved key learnings and met all study objectives Clinically meaningful pain reduction with 100% of responders achieving zero opioid use at 7 days post-procedure and 73% of responders [...]
Folia Health and Inspire are Partnering to Bring Personalized Home Health Observations to the Forefront of Patient Focused Drug Development Research
30/04/2025
BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- Folia Health, the pioneer of patient-driven Home Reported Outcomes (HRO), has partnered with Inspire, the world's leading online health community and real-world data platform, [...]
First AI-Driven Cognitive and Speech Therapy Platform for Spanish, English-Speaking Indian Communities
30/04/2025
Constant Therapy removes language barriers for non-native speakers with stroke, brain injury, or neurological conditions LEXINGTON, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Constant Therapy Health , a pioneer in [...]
Appendix 4C – Q3 FY25 Quarterly Cash Flow Report
30/04/2025
Highlights Reported positive topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) led by robust clinical efficacy Phase 2 data featured in an oral presentation at [...]
BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified
30/04/2025
Phase 3 clinical data shows potential predictive biomarkers for treatment response, first identified in Phase 2 study Biomarkers could be utilized to predict and provide better patient outcomes, including response rates [...]
Senti Bio to Present at the Citizens JMP Life Sciences Conference
30/04/2025
Live video webcast presentation on Thursday, May 8 th at 1:00 PM ET Presentation will highlight the recently announced positive preliminary clinical results of lead program, SENTI-202, in the treatment of patients with [...]
InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference
30/04/2025
MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced [...]
Helius Medical Technologies Announces Reverse Stock Split
30/04/2025
NEWTOWN, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for [...]
Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting
30/04/2025
MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2 SK ), engineered to precisely deliver clinically validated anti-PD1 and IL-2 SK to the tumor microenvironment (TME) IL- [...]
PharmAla Issues Q2 Financial Statements
30/04/2025
TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Magnesium Breakthrough Under Review: Does BiOptimizers Magnesium Breakthrough Work? Best Magnesium Supplements!
30/04/2025
Find out why BiOptimizers Magnesium Breakthrough is consistently rated one of the best magnesium supplements by experts and real users. Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- Stress is responsible for a [...]
Bioma Probiotics Reviews: Best Probiotic For Gut Health & Weight Loss Ingredients & Side Effects
30/04/2025
Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- In the present health-aware world, probiotics have become a pillar for the upkeep of gut health and general well-being. Among the numerous choices out there, Bioma [...]
Better Choice Company Completes Name Change to SRx Health Solutions Inc. and Begins Trading Under the Ticker Symbol ‘SRXH’ Today, Wednesday, April 30, 2025
30/04/2025
TAMPA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (NYSE American: SRXH) (“Better Choice” or the “Company”), a leading global health and wellness company, today announced [...]
Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update
30/04/2025
VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence [...]
Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
30/04/2025
– Pearce joins NHL Hall-of-Famer, Henrik Lundqvist, to educate patients and caregivers about the importance of accurate and early diagnosis of recurrent pericarditis, a chronic autoinflammatory disease of the heart that [...]
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
30/04/2025
— Successfully demonstrates strong tolerability, sustained drug release and safety SARASOTA, FL, April 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo,” or the “Company”), a developmental stage [...]
SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time
30/04/2025
DENVER, April 30, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and [...]
Cellectar Announces Plan to Explore Strategic Alternatives
30/04/2025
FLORHAM PARK, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for [...]
Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
30/04/2025
CORAL GABLES, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and [...]

Pages